Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in GPCR — Structure Therapeutics Inc.

CIK 820027 MINNEAPOLIS, MN
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,371,684
+$1,791,014 QoQ
Shares Held
230,514
+5.0% QoQ
Ownership
0.323%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 190 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 0% Shared 97% None 3%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. GPCR ranks #55 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,604,822 $1,293,893,227
2 INSM
INSMED Inc
 6,179,571 $658,865,856
3 JAZZ
Jazz Pharmaceuticals plc
 1,215,523 $292,904,576
4 RVMD
Revolution Medicines, Inc.
 1,039,702 $194,715,388
5 ARGX
Argenx SE
 181,464 $168,356,853
6 REGN
Regeneron Pharmaceuticals, Inc.
 227,457 $141,828,535
7 MDGL
Madrigal Pharmaceuticals, Inc.
 231,205 $124,145,521
8 BBIO
BridgeBio Pharma, Inc.
 1,551,663 $115,567,858

All Filings in GPCR

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,371,684 230,514
2026-03-31 $10,580,670 219,516
2025-12-31 $19,857,775 285,518
2025-09-30 $34,276,032 1,224,144
2025-06-30 $32,939,223 1,588,198
2025-03-31 $25,650,111 1,481,809
2024-12-31 $38,511,807 1,420,052
2024-09-30 $48,167,120 1,097,451
2024-06-30 $15,976,761 406,844
2024-03-31 $3,885,557 90,657
2023-12-31 $2,557,975 62,757